Howard Cohen
Pain Medicine · Dallas, TXNPI 1962516112
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 266 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 43 manufacturers reported payments, led by AbbVie at 29.2% of the total. Reporting peaked in 2019 at $1,690 and has fallen 61.9% since, to $644 in 2025.
Across 266 payments — averaging $20.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$504
- Teva Pharmaceuticals USA, Inc.$484
- Otsuka America Pharmaceutical, Inc.$298
- Avanir Pharmaceuticals, Inc.$285
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$230
- plus $2K from 37 others
What the payments were for
- Food & beverage$5,534100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,534 in reported general payments places this provider in the 60th percentile of 583 pain medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 33 | $1,195 |
| Gabapentin | 33 | $445 |
| Ondansetron OdtOndansetron | 18 | $208 |
| Tizanidine Hcl | 16 | $206 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 14 | $150 |
| Quetiapine Fumarate | 13 | $118 |
| Lithium Carbonate | 11 | $93 |
| Escitalopram Oxalate | 28 | $92 |
| Celecoxib | 11 | $46 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Dallas
- Justin ThompsonDallas$45K
- Demaceo HowardDallas$39K
- Melissa MurphyGrapevine$653K
- Shiraz YazdaniLubbock$514K
- Aaron CalodneyTyler$296K
- Candice BurnetteSugar Land$265K
- Ashley Bailey-ClassenFort Worth$244K
- Grant ChenHouston$175K
- Gunjan PatelHouston$166K
- Anthony BergRockwall$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.